Breath Analysis News and Research

RSS
Noninvasive Raman device tracks blood glucose accurately in under a minute

Noninvasive Raman device tracks blood glucose accurately in under a minute

Bedfont® Scientific Limited expands global access to FeNO testing in India

Bedfont® Scientific Limited expands global access to FeNO testing in India

New AI tools offer hope for global TB elimination

New AI tools offer hope for global TB elimination

Bedfont® Scientific Limited and Aerosol Medical Systems partner, expanding access to FeNO testing in Latin America

Bedfont® Scientific Limited and Aerosol Medical Systems partner, expanding access to FeNO testing in Latin America

OMED Health partners with Aviva to support the digestive health of employees

OMED Health partners with Aviva to support the digestive health of employees

Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices

Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025

OMED Health launches new gastrointestinal treatments and services through personalized Health Plans

OMED Health launches new gastrointestinal treatments and services through personalized Health Plans

Bedfont® Scientific Limited expands Middle East reach with Kuwaiti distributor

Bedfont® Scientific Limited expands Middle East reach with Kuwaiti distributor

Bedfont® Scientific Limited joins IFE Group to support young people’s mental health

Bedfont® Scientific Limited joins IFE Group to support young people’s mental health

World Wellbeing Week: Bedfont® Scientific Limited highlights ongoing investment in employee wellbeing

World Wellbeing Week: Bedfont® Scientific Limited highlights ongoing investment in employee wellbeing

Bedfont® Scientific Limited kicks-off in charity football match supporting local food education charity, Communigrow

Bedfont® Scientific Limited kicks-off in charity football match supporting local food education charity, Communigrow

Bedfont® Scientific Limited announces strategic partnership for the piCO™ Smokerlyzer® carbon monoxide (CO) device

Bedfont® Scientific Limited announces strategic partnership for the piCO™ Smokerlyzer® carbon monoxide (CO) device

WayBetter’s QuitBet app wins digital health award at Society of Behavioral Medicine conference

WayBetter’s QuitBet app wins digital health award at Society of Behavioral Medicine conference

Bedfont® Scientific Limited sponsors annual Bluebell Walk to raise vital funds for Heart of Kent Hospice

Bedfont® Scientific Limited sponsors annual Bluebell Walk to raise vital funds for Heart of Kent Hospice

New data highlights urgent need for better asthma care – How FeNO testing can help reduce hospitalizations

New data highlights urgent need for better asthma care – How FeNO testing can help reduce hospitalizations

Bedfont® Scientific Limited ranks 28th in MegaGrowth 50 awards 2025

Bedfont® Scientific Limited ranks 28th in MegaGrowth 50 awards 2025

SEHTA Healthcare Business Awards recognizes Bedfont® Scientific Limited for innovation

SEHTA Healthcare Business Awards recognizes Bedfont® Scientific Limited for innovation

Bedfont® Scientific Limited Concludes the Shaun in the Heart of Kent Trail by Presenting a CELLER8® Device to a Successful Participant

Bedfont® Scientific Limited Concludes the Shaun in the Heart of Kent Trail by Presenting a CELLER8® Device to a Successful Participant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.